Holen Sie sich die Stockscreener-App
14.37
0.14%
0.0499
Zymeworks Inc. Aktie (ZYME) Neueste Nachrichten
What drives Zymeworks Inc. stock priceFree Market Dynamics Reports - Autocar Professional
Zymeworks Inc. (NYSE:ZYME) Shares Sold by Arizona State Retirement System - Defense World
What analysts say about Zymeworks Inc. stockGame-changing returns - jammulinksnews.com
Zymeworks Announces Pricing of $100.0 Million Public Offering - Finance Monthly
Zymeworks Inc. Stock Analysis and ForecastTremendous gains - jammulinksnews.com
Teacher Retirement System of Texas Cuts Stock Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Is Zymeworks Inc. a good long term investmentFree Buy/Sell Signal Notifications - PrintWeekIndia
Zymeworks (ZYME) Surges 7.1%: Is This an Indication of Further Gains? - MSN
Zymeworks to Announce Q2 2025 Financials and Engage in Investor Conferences - The Globe and Mail
Zymeworks to Report Second Quarter 2025 Financial Results and Ho - GuruFocus
Zymeworks Inc. to Release Second Quarter 2025 Financial Results on August 7, 2025 - Quiver Quantitative
Zymeworks to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 - GlobeNewswire
Zymeworks Inc. (NYSE:ZYME) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
What makes Zymeworks Inc. stock price move sharplyFree Stock Portfolio Optimization - Newser
How Zymeworks Inc. stock performs during market volatilityFree Stock Market Practical Discussion Forums - Newser
Why Zymeworks Inc. stock attracts strong analyst attentionPortfolio Boosting Stock Alerts - Newser
Janney Montgomery Scott LLC Boosts Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks sees $3.62 million stock purchase by EcoR1 Capital - Investing.com Nigeria
Zymeworks Inc.(NasdaqGS: ZYME) dropped from Russell Small Cap Comp Value Index - MarketScreener
Zymeworks Amends Warrant Agreement with EcoR1 Capital - TipRanks
All You Need to Know About Zymeworks (ZYME) Rating Upgrade to Buy - Yahoo Finance
Wall Street Analysts See a 76.74% Upside in Zymeworks (ZYME): Can the Stock Really Move This High? - MSN
Zymeworks Inc (NASDAQ:ZYME) Valuation Biotech Sector Trends S&P 500 - Kalkine Media
There's Reason For Concern Over Zymeworks Inc.'s (NASDAQ:ZYME) Price - simplywall.st
SG Americas Securities LLC Raises Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks: Early-Stage Biotech Feel Despite Zanidatamab Advancements (Downgrade) (ZYME) - Seeking Alpha
Bank of America Corp DE Sells 38,030 Shares of Zymeworks Inc. (NYSE:ZYME) - Defense World
Transcript : Zymeworks Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-11-2025 02 - MarketScreener
Zymeworks’ Drug Gets Conditional Approval For Biliary Tract Cancer Treatment In China: Retail Sentiment Refuses To Budge - MSN
ZYMEZymeworks Provides Corporate Update and Reports First Quarter 2025 Financial Results - Revista ADVFN
Zymeworks Inc. (NYSE:ZYME) Shares Acquired by Nuveen Asset Management LLC - Defense World
Zymeworks Inc. (NYSE:ZYME) Shares Sold by Jane Street Group LLC - Defense World
BNP Paribas Financial Markets Takes $108,000 Position in Zymeworks Inc. (NYSE:ZYME) - Defense World
Zymeworks gets China's conditional approval for biliary tract cancer treatment - MSN
4.79%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):